Discover 1,397 paid clinical trials in Cleveland, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,397
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
for
Crohn's Disease, Obesity or Overweight
Location: Westlake OH, London, Indianapolis IN, Chevy Chase MD,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70
Code: NCT06937099
Phase3, Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
for
Ulcerative Colitis, Obesity or Overweight
Location: Westlake OH, London, Indianapolis IN, Chevy Chase MD,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70
Code: NCT06937086
Phase3, Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate,
Location: Westlake OH, Springboro OH, Wyoming MI, New Albany IN,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07415044
Phase2, Recruiting
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool
for
Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis),
Location: Westlake OH, Miami FL
Sponsor: American Laboratory Products Company
Sex: All
Age: 22+
Code: NCT06810518
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
for
Metabolic Dysfunction-associated Steatohepatitis
Location: Westlake OH, Springboro OH, New York NY, St Louis MO,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT07704892
Phase3, Recruiting
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
for
Hodgkin Lymphoma in Remission, Leukemia in Remission,
Location: Akron OH, Detroit MI, Cincinnati OH, Rochester NY,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT01790152
Recruiting
A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee
for
Chondral Defect, Osteochondritis Dissecans (OCD),
Location: Akron OH, Ann Arbor MI, Columbus OH, Baltimore MD,
Sponsor: Vericel Corporation
Sex: All
Age: 10 - 17
Code: NCT03588975
Phase3, Recruiting
Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis
for
Liver Fibrosis, Hepatic Cirrhosis
Location: Westlake OH, Raleigh NC, Clarksville TN, St Louis MO,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07610837
Phase2, Recruiting
Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH
A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)
Location: Westlake OH, Clinton Township MI, Chicago IL,
Sponsor: Rivus Pharmaceuticals, Inc.
Sex: All
Age: 30+
Code: NCT07491458
Phase2, Recruiting
QL Block in Laparoscopic Myomectomy
for
Postoperative Pain, Fibroid Uterus
Location: Beachwood OH
Sponsor: Joseph Findley MD
Sex: Female
Age: 18 - 45
Code: NCT05979493
Recruiting
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
for
Schizophrenia
Location: Westlake OH, Baltimore MD, Evanston IL, Belle Mead NJ,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07101094
Recruiting
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
for
Transthyretin Amyloidosis With Cardiomyopathy
Location: Cleveland OH, Detroit MI, London, Columbus OH, Toronto,
Sponsor: Alnylam Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07052903
Phase3, Recruiting
Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty